Phillips Petroleum Company was an American oil company incorporated in 1917 that expanded into petroleum refining, marketing and transportation, natural gas gathering and the chemicals sectors. On August 30, 2002, Conoco Inc. merged with Phillips Petroleum to form ConocoPhillips, becoming the third largest integrated energy company and second-largest refining company in the United States. The company moved its headquarters to Houston.

Genomic Health, Inc. (NASDAQ: GHDX) is a provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.

Crystal Bioscience is a privately-held company that was founded in 2008 to develop a therapeutic antibody discovery engine using chickens. Its platform relies on the large phylogenetic distance between mammals and birds to generate a diverse array of antibodies to human targets that have proven intractable in mammalian and other discovery platforms.

Hill's Pet Nutrition, Inc. provides pet food products and pet care services. It offers products to the breeders, veterinarians, and pet supply retailers. The company was founded by Mark L. Morris in 1939 and is headquartered in Topeka, KS.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

METabolic EXplorer is a biochemistry company that develops industrial alternatives to petrochemical processes. It offers chemical manufacturers viable, long-term alternatives based on renewable resources. METabolic EXplorer considers the economic performance of each production process to be a fundamental factor of competitiveness in relation to petrochemical processes. It is continually working to improve the efficiency of microorganisms and to make its technologies more competitive, notably by diversifying the supply of renewable raw materials. The company aims to produce basic chemical compounds that already have a large number of industrial applications essential to everyday life.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA.

Ark Therapeutics Ltd. engaged in manufacturing of pharmaceutical products. The company was founded on April 30, 2018 and is headquartered in London, the United Kingdom.

CompleGen is an early-stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Their system is used to build compound discovery systems for a broad range of therapeutic targets for the pharmaceutical industry, as well as efficient cost-effective product discovery systems for the agricultural industry.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Novozymes Berlin GmbH operates as a research and development company. It focuses on products and processes derived from microbial strains. The company was founded in 2001 and is headquartered in Berlin, Germany.

Valentis’ technology combines nanocrystalline cellulose (NCC), a biodegradable, transparent material made from plant pulp waste, with additional nanoparticles to produce highly improved polymeric films. Incorporating different nanoparticles into Valentis’ composites adds new functionality (for example, piezoelectric or antibacterial properties) that can be tailored to specific applications and needs. The company’s first product is a coating for use in the food industry to create packaging material that is thinner, transparent, stronger, and provides a high barrier against UV rays, oxygen, and moisture.

Hunan Meida Biological Resources Co., Ltd., established on 2006-04-03, Business scope includes veterinary medicine,Feed additives,Research and development of additive premixed feed,Production,Sales;Pet Health Products,Research and development of cosmetic raw materials and daily chemical products(Excluding production and sales);Fine Chemicals(Free of Hazardous Chemicals),Plant extracts(No pre-approval items required)research and development,production and sales;Collection and management of primary agricultural products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Biocept, an emerging biotechnology leader in cell separation technology, is developing a new, powerful class of diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. The CEEâ„¢ Cell Enrichment and Extraction platform combines sophisticated attachment chemistry with mathematically modeled fluid dynamics to enable earlier, accurate, less invasive diagnoses. Isolation, purification and analysis of rare cells are managed within their state-of-the-art CLIA-accredited laboratory. The clinical laboratory is accredited by the College of American Pathologists (CAP) and holds licenses in California and several other states.

Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever